secwatch.observer — SEC 8-K summary
======================================

Issuer:     OnKure Therapeutics, Inc. (OKUR)
CIK:        0001637715
Form:       8-K
Filed at:   2026-06-04T20:15:16+00:00
Accession:  0001193125-26-257423
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Stockholders approve amended 2024 equity plan with 3.23M share increase and modified evergreen provision
--------------------------------------------------------------------------------

- Shareholders approved one-time increase of 3,231,638 shares (approx. 8% of outstanding) to the 2024 Equity Incentive Plan.
- Annual evergreen provision amended: fixed cap of 2,407,100 shares removed; future annual increase set at 5% of outstanding shares beginning FY2027.
- Directors R. Michael Carruthers, Valerie M. Jansen, and Edward T. Mathers elected as Class II directors until 2029.
- Shareholders ratified KPMG LLP as independent auditor for fiscal year ending Dec. 31, 2026.
- Incentive stock option limit under plan set at 8 million shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1637715/000119312526257423/0001193125-26-257423-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1637715/000119312526257423/okur-20260603.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-257423

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer